2023 will be a big year for AbbVie. The company's transition from a Humira-dependent enterprise to one with multiple green…
Listen to the podcast below or on the go via Apple Podcasts or Spotify. Green Growth Giants' Owen Clendenin shares…
Listen on the go! Subscribe to Wall Street Breakfast on Apple Podcasts and Spotify This is an abridged conversation from…
Author's Note: This article was published on iREIT on Alpha in April of 2022. Dear subscribers, So, AvalonBay (NYSE:AVB). I've…
Introduction It's time to discuss Steel Dynamics (NASDAQ:STLD). This Indiana-based steel giant is one of America's best-performing industrial stocks and…
The S&P 500 has broken out of a formation that projects a 4300 target. This projection is supported by higher…
Two small deals priced this past week, neither of which were eligible for inclusion in our IPO stats, while one…
It happens to everyone. It will happen to you, too. There’s no escaping it. Sooner or later, you’ll be toiling…
Sign in to your account
